Dáil Éireann Debate, Thursday - 4 December 2025
539. Deputy Barry Ward asked the Minister for Health if dupilumab will be made available through the HSE for the treatment of juvenile eosinophilic oesophagitis; and if she will make a statement on the matter. [68978/25]
Amharc ar fhreagraUnder the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for decisions on the pricing and reimbursement of medicines and medical devices; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.
